Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	14.32	60.55	52.97
Graham Fair Price	1.40	65.62	64.72
PEG	12318.69	79.55	-0.64
Price/Book	14.89	3.92	3.42
Price/Cash Flow	-65.60	128.51	-373.55
Prices/Earnings	17.42	33.99	28.95
Price/Sales	8.69	3.29	3.02
Price/FCF	-65.60	128.51	-373.55
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-17.02	0.20	0.24
Operating Margin	2.30	0.04	0.03
ROA	-2.11	0.01	0.01
ROE	0.03	0.03	-2.15
ROIC	0.02	0.02	11.40
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	< 0.005	92.88
Dividends QOQ	< 0.005	< 0.005	-1196.92
EBIT QOQ	-0.45	0.11	-76.36
EPS QOQ	-0.45	< 0.005	-99.05
FCF QOQ	-1.19	4.42	272.66
Revenue QOQ	-0.18	0.08	-55.04
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	14.68	13.33	-9.18
Days Sales Outstanding (DSO)	4.28	4.22	-1.45
Inventory Turnover	6.13	6.75	10.11
Debt/Capitalization	0.36	0.35	-1.50
Quick Ratio	0.38	0.39	3.10
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	79.45	81.44	2.51
Cash	4.79	5.58	16.31
Capex	-4.04	-5.30	-31.31
Free Cash Flow	-0.73	2.49	242.32
Revenue	89.74	97.23	8.35
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.89	0.87	-1.83
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.70	6.53	-2.65
Naive Interpretation	Member

06 - Financial Health · Bad

Rating